Literature DB >> 25060990

Prognostic value of histologic grading for feline mammary carcinoma: a retrospective survival analysis.

S W Mills1, K M Musil2, J L Davies3, S Hendrick4, C Duncan5, M L Jackson4, B Kidney4, H Philibert4, B K Wobeser4, E Simko4.   

Abstract

Feline mammary carcinoma is highly malignant and generally associated with a poor prognosis, although studies suggest the range of survival times in affected cats is broad. Histologic grading of these tumors is achieved using the Elston and Ellis system, originally developed for human breast cancer. In cats, however, classification using this method has variable prognostic value. Therefore, objectives of this study were (1) to evaluate the Elston and Ellis grading system for feline mammary carcinoma in a predominantly spayed population and (2) to determine whether modification of this system or development of a novel system improved the prognostic value of histologic grading. Survey data and histologic features for 108 carcinomas from 97 cats were analyzed with respect to overall survival. Elston and Ellis grading failed to correlate significantly with overall survival. Using multivariable analysis, lymphovascular invasion, nuclear form, and mitotic count each demonstrated independent prognostic significance (P = .008, <.001, and .004, respectively). Modifications of the Elston and Ellis system and a novel grading system were proposed based on these results; all showed significant correlation with overall survival (P < .001). Median survival times were 27, 29, or 31 months for grade I; 14, 12, or 14 months for grade II; and 13, 5, or 8 months for grade III carcinomas using the mitotic-modified Elston and Ellis, the revised Elston and Ellis, or the novel grading system, respectively. Based on this retrospective study, adoption of the species-specific systems as proposed here may improve the prognostic value of histologic grading for feline mammary carcinoma. © American College of Veterinary Pathologists 2014.

Entities:  

Keywords:  Elston and Ellis; feline mammary carcinoma; grading; prognosis; retrospective postoperative survival; tumor histology

Mesh:

Year:  2014        PMID: 25060990     DOI: 10.1177/0300985814543198

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  17 in total

1.  Is melatonin of value in cancer treatment? Experience with a case of feline mammary carcinoma.

Authors:  Beverly Baxter
Journal:  Can Vet J       Date:  2017-07       Impact factor: 1.008

2.  St Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study.

Authors:  M Soares; J Correia; M C Peleteiro; F Ferreira
Journal:  Tumour Biol       Date:  2015-10-20

3.  The anti-proliferative and apoptotic effects of curcumin on feline mammary gland tumor cells in vitro.

Authors:  A Deveci Ozkan; G Guney Eskiler; O Turna; N Kazan; E Sozen Kucukkara; A Baykal; K Sonmez
Journal:  Iran J Vet Res       Date:  2021       Impact factor: 1.376

4.  Investigating the role of signal transducer and activator of transcription 3 in feline injection site sarcoma.

Authors:  Cheng-Hsin Shih; Yen-Chen Chang; Yun-Chiang Lai; Hue-Ying Chiou
Journal:  BMC Vet Res       Date:  2022-07-14       Impact factor: 2.792

5.  Feline Mammary Cancer.

Authors:  B B Hassan; S M Elshafae; W Supsavhad; J K Simmons; W P Dirksen; S M Sokkar; T J Rosol
Journal:  Vet Pathol       Date:  2016-07-11       Impact factor: 2.221

6.  Intermediate-grade mammary gland adenocarcinoma in an 18-year-old female black leopard (Panthera pardus) with acute pancreatic necrosis and chronic interstitial nephropathy.

Authors:  Misato Nakamura; Toshinori Yoshida; Ayumi Eguchi; Mari Inohana; Rei Nagahara; Ayako Shiraki; Nanao Ito; Makoto Shibutani
Journal:  J Vet Med Sci       Date:  2017-12-19       Impact factor: 1.267

7.  Evaluation of the histopathological extent of neoplastic infiltration in intestinal tumours in cats.

Authors:  Michael Morrice; Gerry Polton; Sam Beck
Journal:  Vet Med Sci       Date:  2019-03-11

8.  Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 2: Feline Mammary Carcinomas.

Authors:  Florian Chocteau; Marie-Mélanie Boulay; Fanny Besnard; Germain Valeau; Delphine Loussouarn; Frédérique Nguyen
Journal:  Front Vet Sci       Date:  2019-11-07

9.  Expression of HIF-1α and VEGF in feline mammary gland carcinomas: association with pathological characteristics and clinical outcomes.

Authors:  Bo Chen; Susanne Je-Han Lin; Wen-Ta Li; Hui-Wen Chang; Victor Fei Pang; Pei-Yi Chu; Chin-Cheng Lee; Hiroyuki Nakayama; Ching-Ho Wu; Chian-Ren Jeng
Journal:  BMC Vet Res       Date:  2020-05-06       Impact factor: 2.741

10.  Analysis of Copy-Number Variations and Feline Mammary Carcinoma Survival.

Authors:  Hugo Murua Escobar; Ingo Nolte; José Luis Granados-Soler; Kirsten Bornemann-Kolatzki; Julia Beck; Bertram Brenig; Ekkehard Schütz; Daniela Betz; Johannes Junginger; Marion Hewicker-Trautwein
Journal:  Sci Rep       Date:  2020-01-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.